Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Dushianthan, S. Packham (Swansea, United Kingdom). Sputum analysis and management of non-CF bronchiectasis in Singleton hospital. Eur Respir J 2008; 32: Suppl. 52, 270

Member's Comments

No comment yet.

Related content which might interest you: Inpatient management of non-CF bronchiectasis: Should patients be managed as in CF? Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Challenges in the management of non-CF bronchiectasis Source: International Congress 2016 – Challenges in the management of non-CF bronchiectasis Year: 2016 Sputum microbiology in patients with stabile COPD Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Predicting hospital admissions in non-CF bronchiectasis using COPD specific severity tools Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Sputum galactomannan in COPD patients with and without bronchiectasis Source: International Congress 2017 – Bronchial asthma management Year: 2017 Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Analysis of microbiological colonization in COPD patients with or without bronchiectasis Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Sputum proteomics of CF, BE and COPD with or without NTM infections Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021 Prediction of imminent COPD exacerbations by sputum analysis Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003 Non-CF bronchiectasis: cell population in sputum Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation Year: 2007 Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2009; 33: 361-364 Year: 2009 Bacterial etiology of exacerbations of non-cystic fibrosis bronchiectases in young patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Fever, hospitalization and healthcare utilization after research bronchoscopy Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Leicester cough questionnaire and sputum colour chart assessment in non-cystic fibrosis bronchiectasis: A cohort analysis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011 Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis Source: International Congress 2017 – COPD and weaning Year: 2017 Knowledge and adherence of airway clearance techniques in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Respiratory physiotherapy: outcomes in disease and health Year: 2015 Time to diagnosis and adherence to guidelines in a large cohort of patients with non-CF bronchiectasis Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 Role of bronchoalveolar lavage in new sputum smear negative pulmonary tuberculosis patients Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016